# Pulmonary Embolism: Mechanism and Therapeutic Innovation

> **NCT05360992** · — · COMPLETED · sponsor: **China National Center for Cardiovascular Diseases** · enrollment: 1200 (actual)

## Conditions studied

- Pulmonary Embolism

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05360992
- **Lead sponsor:** China National Center for Cardiovascular Diseases
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2021-10-13
- **Final completion:** 2021-10-13
- **Target enrollment:** 1200 (ACTUAL)
- **Last updated:** 2022-05-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05360992

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05360992, "Pulmonary Embolism: Mechanism and Therapeutic Innovation". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05360992. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*